July 25, 2018 07:00 AM EDT

With a new HQ under construction and AbbVie as a partner, Alector grabs $133M round to fund a move into the clinic

John Carroll

Editor & Founder

When Sabah Oney joined Alector three years ago, the two-year-old company helmed by CEO Arnon Rosenthal had a lean, 15-staffer operation tightly packed into one …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

With a new HQ under construction and AbbVie as a partner, Alector grabs $133M round to fund a move into the clinic

John Carroll

Editor & Founder

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Here's what today's Fed rate cut means for biotech, pharma and venture capital

FDA cancels Applied Therapeutics adcomm, shares skyrocket 65%

All of 23andMe's independent board members resign over disagreements with CEO

Roivant makes another deal, selling Dermavant to Organon for up to $1.2B

With few efficacy details, Insilico claims a Phase 2a win in latest AI readout

Breaking down silos with a new quantitative approach to drug development

With a new HQ un­der con­struc­tion and Ab­b­Vie as a part­ner, Alec­tor grabs $133M round to fund a move in­to the clin­ic

Editor & Founder

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

With a new HQ under construction and AbbVie as a partner, Alector grabs $133M round to fund a move into the clinic